Chlorthalidone, a long-acting diuretic prescribed for high blood pressure, causes side effects that are largely tied to how it works: by pushing your kidneys to remove more salt and water. The most common issues involve electrolyte imbalances (especially low potassium), dizziness when standing up, frequent urination, and digestive upset. Most side effects are dose-dependent, meaning they become more likely at higher doses, and many appear within the first few weeks of treatment.
Everyday Side Effects
The side effects you’re most likely to notice day to day include frequent urination, dizziness or lightheadedness (particularly when standing up from a sitting or lying position), headache, nausea, upset stomach, vomiting, diarrhea, and loss of appetite. The dizziness tends to be most noticeable when you first start taking the medication and often improves as your body adjusts.
Because chlorthalidone stays active in your body for 48 to 72 hours, much longer than many similar medications, its effects are more sustained. That extended activity is part of why it’s effective at lowering blood pressure, but it also means side effects can linger longer than you might expect from a single dose.
Low Potassium Is the Big One
The side effect that gets the most clinical attention is low potassium, known as hypokalemia. This is clearly dose-related, and the numbers are striking. In clinical studies, low potassium occurred in 30% of people taking 12.5 mg daily, 40% at 25 mg, 58% at 50 mg, and 68% at 75 mg. By comparison, only 5% of people on placebo had the same problem.
Low potassium matters because potassium is essential for normal heart rhythm and muscle function. Symptoms can include muscle cramps, weakness, fatigue, and in more severe cases, irregular heartbeat. This is the main reason your doctor will order blood tests after starting chlorthalidone, typically within two to four weeks, then periodically after that. Once your levels stabilize, testing can be spaced out to every three months or so. People with diabetes, frequent vomiting, or diarrhea need more frequent monitoring because those conditions already stress your electrolyte balance.
Low Sodium Risk
Chlorthalidone also carries a higher risk of low sodium compared to the more commonly prescribed hydrochlorothiazide. A study published in The American Journal of Medicine found that at equal doses, chlorthalidone roughly doubled the odds of dangerously low sodium levels. Two factors explain this: chlorthalidone activates parts of the nervous system that increase levels of a hormone causing your body to retain water (diluting sodium), and its much longer half-life of 35 to 67 hours (versus 7 to 11 hours for hydrochlorothiazide) means it’s working around the clock.
Low sodium symptoms include confusion, nausea, headache, and in severe cases, seizures. Older adults are especially vulnerable because their kidneys are less efficient at compensating.
Uric Acid and Gout
Chlorthalidone raises uric acid levels by increasing how much uric acid your kidneys reabsorb back into your bloodstream. An analysis of FDA adverse event reports found that chlorthalidone users reported gout at five times the rate of the background population. The mechanism is straightforward: the drug causes salt and water loss, which triggers your kidneys to pull more uric acid back into the blood. Over time, that extra uric acid can crystallize in joints, causing the intense pain of a gout attack.
If you have a history of gout or already run high uric acid levels, this is worth discussing before starting the medication. The risk applies to all thiazide-type diuretics, but chlorthalidone’s longer duration of action means the effect is more persistent.
Blood Sugar Changes
Chlorthalidone can raise blood sugar levels, which is particularly relevant if you have diabetes or prediabetes. This metabolic effect is another reason your doctor may check blood work regularly after starting treatment. The blood sugar increase is generally modest in people with normal glucose metabolism, but for those already on the edge of diabetes, it can be enough to tip the balance.
Erectile Dysfunction
Sexual side effects are a real concern, particularly for men. The Treatment of Mild Hypertension Study (TOMHS), one of the most rigorous trials on this topic, found that 17.1% of men on chlorthalidone reported erection problems within the first 24 months, compared to 8.1% on placebo. At the 24-month mark specifically, 15.7% of the chlorthalidone group had difficulty obtaining an erection versus 4.9% on placebo.
There’s a silver lining in the data, though. Most men who developed this problem experienced it within the first year (8 out of 12 affected men in the study). The majority of them stayed on the medication despite it. By 48 months, the gap between chlorthalidone and placebo had narrowed considerably and was no longer statistically significant, with rates of 18.3% versus 16.7%. New erection problems after two years of use were unlikely. So this appears to be an early side effect that either resolves or becomes something men adapt to.
How It Compares to Hydrochlorothiazide
Since many people are switched between chlorthalidone and hydrochlorothiazide (HCTZ), the comparison matters. Chlorthalidone is about 1.5 to 2 times as potent as HCTZ, which means you need a lower dose to get the same blood pressure reduction. A typical starting dose is 6.25 mg for older adults and 12.5 mg for younger patients, with a maximum of 25 mg. For HCTZ, the equivalent starting doses are 12.5 mg and 25 mg, with a 50 mg ceiling.
The trade-off for that extra potency is a somewhat higher rate of electrolyte side effects, particularly low potassium and low sodium. Chlorthalidone’s effects last 48 to 72 hours per dose, compared to 16 to 24 hours for HCTZ with long-term dosing. That longer action is beneficial for consistent blood pressure control but leaves less recovery time for your electrolyte balance between doses.
Side Effects Are Dose-Dependent
One of the most practical things to understand about chlorthalidone is that nearly all its side effects get worse at higher doses. The jump from 12.5 mg to 25 mg increases hypokalemia risk from 30% to 40%. Going up to 50 mg pushes it to 58%. Meanwhile, the blood pressure benefit of higher doses flattens out, meaning doubling the dose doesn’t double the effect but does substantially increase side effects.
This is why current prescribing guidelines favor starting at the lowest effective dose and increasing cautiously. If you’re experiencing side effects, asking about a dose reduction is a reasonable conversation to have, since even small reductions can meaningfully lower your risk of electrolyte problems while still controlling blood pressure.